Home/Filings/4/0000875320-24-000144
4//SEC Filing

Atkinson Edward Morrow III 4

Accession 0000875320-24-000144

CIK 0000875320other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:12 PM ET

Size

5.0 KB

Accession

0000875320-24-000144

Insider Transaction Report

Form 4
Period: 2024-05-14
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
  • Award

    Common Stock

    2024-05-14+14,11230,084 total
Footnotes (1)
  • [F1]Represents earned performance shares with respect to a performance stock unit award granted on 05/19/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 05/14/2024 and the shares will vest on 06/10/2024.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001914164

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:12 PM ET
Size
5.0 KB